Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: A single institution experience

Clinical Lymphoma, Myeloma and Leukemia

Volumn 13, Issue 1, 2013, Pages 8-14

  Voss, Martin H ^a   Lunning, Matthew A ^a   Maragulia, Jocelyn C ^a   Papadopoulos, Esperanza B ^a   Goldberg, Jenna ^a   Zelenetz, Andrew D ^a   Horwitz, Steven M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Peripheral; TCR gamma delta

Indexed keywords

ADALIMUMAB; ALEMTUZUMAB; BUSULFAN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IFOSFAMIDE; INFLIXIMAB; MELPHALAN; MERCAPTOPURINE; PENTOSTATIN; PREDNISONE; THIOTEPA; THYMOCYTE ANTIBODY; VINCRISTINE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG MEGADOSE; EARLY INTERVENTION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEPATOSPLENIC T CELL LYMPHOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDUCTION CHEMOTHERAPY; LONG TERM SURVIVAL; MALE; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY; T CELL LYMPHOMA; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INDUCTION CHEMOTHERAPY; LIVER NEOPLASMS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPLENIC NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873311535     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2012.09.002     Document Type: Article

References (55)

1. J.P. Farcet, P. Gaulard, J.P. Marolleau Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta Blood 75 1990 2213 2219
2. N.L. Harris, E.S. Jaffe, H. Stein A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma Study Group Blood 84 1994 1361 1392
3. N.L. Harris, E.S. Jaffe, J. Diebold Lymphoma classification-from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms Ann Oncol 11 Suppl 1 2000 3 10
4. F. Vega, L.J. Medeiros, P. Gaulard Hepatosplenic and other gammadelta T-cell lymphomas Am J Clin Pathol 127 2007 869 880
5. P. Gaulard, K. Belhadj, F. Reyes Gammadelta T-cell lymphomas Semin Hematol 40 2003 233 243
6. N.L. Harris, E.S. Jaffe, J. Diebold The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues Report of the clinical advisory committee meeting, Airlie house, Virginia, November, 1997 Ann Oncol 10 1999 1419 1432
7. E.S. Jaffe, N.L. Harris, J. Diebold World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues A progress report Am J Clin Pathol 111 Suppl 1 1999 S8 S12
8. P. Gaulard, P. Bourquelot, P. Kanavaros Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas Identification of a subset of gamma/delta T-cell lymphomas Am J Pathol 137 1990 617 628
9. K.F. Wong, J.K. Chan, E. Matutes Hepatosplenic gamma delta T-cell lymphoma A distinctive aggressive lymphoma type Am J Surg Pathol 19 1995 718 726
10. S.Z. Wei, T.H. Liu, D.T. Wang Hepatosplenic gammadelta T-cell lymphoma World J Gastroenterol 11 2005 3729 3734
11. C.B. Cooke, L. Krenacs, M. Stetler-Stevenson Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin Blood 88 1996 4265 4274
12. E. Weidmann Hepatosplenic T cell lymphoma A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990 Leukemia 14 2000 991 997
13. H. Wu, M.A. Wasik, G. Przybylski Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients Am J Clin Pathol 113 2000 487 496
14. W.A. Khan, L. Yu, A.B. Eisenbrey Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients Report of two cases and review of literature Am J Clin Pathol 116 2001 41 50
15. M. Steurer, R. Stauder, K. Grünewald Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation Hum Pathol 33 2002 253 258
16. R. Hassan, S.A. Franco, C.G. Stefanoff Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections Pathol Int 56 2006 668 673
17. A. François, J.F. Lesesve, A. Stamatoullas Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q Am J Surg Pathol 21 1997 781 790
18. J.F. Colombel, E.V. Loftus Jr., W.J. Tremaine The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients Gastroenterology 126 2004 19 31
19. L. Peyrin-Biroulet, P. Deltenre, N. de Suray Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials Clin Gastroenterol Hepatol 6 2008 644 653
20. A. Zeidan, R. Sham, J. Shapiro Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy Leuk Lymphoma 48 2007 1410 1413
21. A.C. Mackey, L. Green, L.C. Liang Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease J Pediatr Gastroenterol Nutr 44 2007 265 267
22. J.R. Rosh, T. Gross, P. Mamula Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis 13 2007 1024 1030
23. J.R. Rosh, M. Oliva-Hemker Infliximab use and hepatosplenic T cell lymphoma: questions to be asked and lessons learned J Pediatr Gastroenterol Nutr 44 2007 165 167
24. A. Kandiel, A.G. Fraser, B.I. Korelitz Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine Gut 54 2005 1121 1125
25. K. Belhadj, F. Reyes, J.P. Farcet Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients Blood 102 2003 4261 4269
26. F. Vega, L.J. Medeiros, C. Bueso-Ramos Hepatosplenic gamma/delta T-cell lymphoma in bone marrow A sinusoidal neoplasm with blastic cytologic features Am J Clin Pathol 116 2001 410 419
27. W.R. Macon, N.B. Levy, P.J. Kurtin Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas Am J Surg Pathol 25 2001 285 296
28. R. Lai, L.M. Larratt, W. Etches Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia Am J Surg Pathol 24 2000 459 463
29. E.L. Alonsozana, J. Stamberg, D. Kumar Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma Leukemia 11 1997 1367 1372
30. P. Jonveaux, M.T. Daniel, V. Martel Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma Leukemia 10 1996 1453 1455
31. H.C. Rossbach, W. Chamizo, D.P. Dumont Hepatosplenic gamma/delta T-cell lymphoma with isochromosome 7q, translocation t(7;21), and tetrasomy 8 in a 9-year-old girl J Pediatr Hematol Oncol 24 2002 154 157
32. I. Wlodarska, N. Martin-Garcia, R. Achten Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression Genes Chromosomes Cancer 33 2002 243 251
33. G.S. Falchook, F. Vega, N.H. Dang Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment Ann Oncol 20 2009 1080 1085
34. G. Jaeger, F. Bauer, R. Brezinschek Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine Ann Oncol 19 2008 1025 1026
35. S.K. Tey, P.V. Marlton, C.M. Hawley Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen Am J Hematol 83 2008 330 333
36. S. Mittal, B.J. Milner, P.W. Johnston A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab Eur J Haematol Jun 76 2006 531 534
37. M.L. Moleti, A.M. Testi, F. Giona Gamma-delta hepatosplenic T-cell lymphoma Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone Leuk Lymphoma 47 2006 333 336
38. G. Corazzelli, G. Capobianco, F. Russo Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas Haematologica 90 2005 ECR14
39. E. Iannitto, V. Barbera, G. Quintini Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin Br J Haematol 117 2002 995 996
40. J. Ooi, T. Iseki, D. Adachi Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma Haematologica 86 2001 E25
41. A. Gassas, M. Kirby, S. Weitzman Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation Am J Hematol 75 2004 113 114
42. J.A. Domm, M. Thompson, J.F. Kuttesch Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature J Pediatr Hematol Oncol 27 2005 607 610
43. R. Sakai, S. Fujisawa, K. Fujimaki Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 37 2006 537 538
44. V. Procházka, T. Papajík, M. Jarosová T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149 2005 275 276
45. S. He, A. Roberts, D. Ritchie Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma Leuk Lymphoma 48 2007 1448 1450
46. A.I. Chen, A. McMillan, R.S. Negrin Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience Biol Blood Marrow Transplant 14 2008 741 747
47. T. Konuma, J. Ooi, S. Takahashi Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma Leuk Lymphoma 48 2007 630 632
48. S.M. Ansell, T.M. Habermann, P.J. Kurtin Predictive capacity of the international prognostic factor index in patients with peripheral T-cell lymphoma J Clin Oncol 15 1997 2296 2301
49. A. Gallamini, C. Stelitano, R. Calvi Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study Blood 103 2004 2474 2479
50. FDA Tumor necrosis factor (TNF) blockers, azathioprine and/or mercaptopurine: update on reports of hepatosplenic T-cell lymphoma in adolescents and young adults http://www.fda.gov/Safety/MedWatch/ SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm251443.htm Accessed: July 18, 2011
51. J.V. Pozadzides, B. Pro Hepatosplenic T-cell lymphoma and TNF-alpha inhibitors Expert Rev Hematol 2 2009 611 614
52. W.R. Connell, M.A. Kamm, M. Dickson Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease Lancet 343 1994 1249 1252
53. R.J. Farrell, Y. Ang, P. Kileen Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low Gut 47 2000 514 519
54. J.L. Jones, E.V. Loftus Jr Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment? Inflamm Bowel Dis 13 2007 1299 1307
55. E. Baecklund, A. Iliadou, J. Askling Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis Arthritis Rheum 54 2006 692 701